Tom Curran, PhD, FRS

Tom Curran, PhD, is the Director of Basic Scientic Research for the CCCR and is interested in the medulloblastoma patients. His laboratory research has lead to a translational application and clinical trial of a compound that targets specific gene mutations associated with medulloblastoma, potentially paving the way for less toxic treatments.